Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LabCorp buys National Genetics Institute:

This article was originally published in Clinica

Executive Summary

Laboratory Corporation of America (LabCorp) has agreed to buy all of the stock of National Genetics Institute, a privately held provider of molecular diagnostic hepatitis C (HCV) testing. Terms of the agreement, which is expected to close in July, were not disclosed. LabCorp says the deal with Los Angeles-based National Genetics will bring it ultra-sensitive tools to assess HCV disease progress at reviously undetectable levels. We believe infectious disease testing, and specifically hepatitis C testing employing molecular diagnostics, will continue to be one of the fastest growing areas of laboratory testing," said Thomas MacMahon, LabCorp's CEO.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel